Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Bin Zheng

Bin Zheng

University of Oklahoma, USA

Title: Identifying and testing new quantitative image, an analysis based clinical markers to predict breast cancer risk and prognosis

Biography

Biography: Bin Zheng

Abstract

Quantitative image feature analysis plays an important role in cancer screening, diagnosis, and prognosis assessment. In our laboratory, we focus on identifying and testing new quantitative image analysis based clinical markers to help more accurately predict cancer risk and prognosis. In this presentation, I will discuss our work and recent progress in assessing near-term breast cancer risk and breast tumor response to neoadjuvant chemotherapy. First, we applied image feature analysis method based on detection of bilateral mammographic density and tissue asymmetry to build a new machine learning model to predict risk of the individual women developing early breast cancer in the near-term (i.e., within the 2 years after a negative mammography screening). Second, we extracted kinetic image features from breast MR images to build another new model to predict the likelihood of complete response of breast tumors to neoadjuvant chemotherapy. To increase confidence of clinians to consider and/or accept the prediction results of our new models, we also developed and implemented the graphic user interface (GUI) platforms for interactively applying our new image processing scheme and prediction models to process and analyze images. Our preliminary testing results using several image datasets demonstrated that applying the new quantitative image feature analysis based models could yield significantly higher discriminatory power in predicting near-term breast cancer risk and tumor response to the chemotherapy. If it is successfully applied, the new image marker based prediction models has potential to help establish a new and more effective personalized breast cancer screening and/or treatment paradigms in the future.